Kim Brixen
About
In The Last Decade
Kim Brixen
235 papers receiving 8.9k citations
Peers
Comparison fields: 5 of 155
- Orthopedics and Sports Medicine 3.8k
- Oncology 2.5k
- Molecular Biology 2.2k
- Endocrinology, Diabetes and Metabolism 1.7k
- Surgery 1.6k
Countries citing papers authored by Kim Brixen
This map shows the geographic impact of Kim Brixen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Brixen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Brixen more than expected).
Fields of papers citing papers by Kim Brixen
This network shows the impact of papers produced by Kim Brixen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Brixen. The network helps show where Kim Brixen may publish in the future.
Co-authorship network of co-authors of Kim Brixen
This figure shows the co-authorship network connecting the top 25 collaborators of Kim Brixen. A scholar is included among the top collaborators of Kim Brixen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Brixen. Kim Brixen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 72 | |
| 3 | 97 | |
| 4 | 20 | |
| 5 | 95 | |
| 6 | 10 | |
| 7 | 9 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | Sustained 5-year vertebral and non-vertebral fracture risk reduction with strontium ranelate in elderly women with osteoporosis | 5 |
| 11 | Associations between increase in bone mineral density and decrease in clinical vertebral fracture incidence during a treatment with strontium ranelate | 2 |
| 12 | Strontium ranelate reduces the risk of fracture in elderly women with osteoporosis in the first year of treatment | 1 |
| 13 | 46 | |
| 14 | Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia | 3 |
| 15 | Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in Caucasian women with post-menopausal osteoporosis. | 1 |
| 16 | Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis | 2 |
| 17 | 28 | |
| 18 | 8 | |
| 19 | 54 | |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.